BIMI International Medical Inc. Common Stock
BIMI
BIMI was delisted on the 21st of August, 2024.
5 hedge funds and large institutions have $660K invested in BIMI International Medical Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
25% more funds holding
Funds holding: 4 → 5 (+1)
36% less capital invested
Capital invested by funds: $1.03M → $660K (-$373K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$168K |
| 2 |
JP Morgan Chase
New York
|
+$94.6K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
+$56.6K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$42.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
BIMI Hedge Fund Activity: Q1 2019 in Review
5 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q1 2019, worth a combined $660K — down 36% from $1.03M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BIMI positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $168K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $1K sold.
- 5 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q1 2019, up from 4 in Q4 2018.
- Funds reported $660K of BIMI International Medical Inc. Common Stock stock for Q1 2019, down 36% quarter-over-quarter.
- 2 funds opened new BIMI International Medical Inc. Common Stock positions in Q1 2019 and 1 closed out, a net change of +1 holder.
- The largest BIMI International Medical Inc. Common Stock buyer in Q1 2019 was Morgan Stanley, an estimated $168K added.
- The largest BIMI International Medical Inc. Common Stock seller in Q1 2019 was Tower Research Capital (TRC), an estimated $1K sold.
Based on aggregated 13F filings for Q1 2019.